2016
DOI: 10.1016/s0140-6736(16)32187-0
|View full text |Cite|
|
Sign up to set email alerts
|

Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
126
0
4

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 133 publications
(137 citation statements)
references
References 34 publications
7
126
0
4
Order By: Relevance
“…In our cohort, corticosteroid withdrawal showed a beneficial effect on glucose metabolism without compromising allograft outcome. This is in line with the recently published HARMONY trial [40]. However, studies investigating the benefit of corticosteroid withdrawal or avoidance for PTDM risk yielded conflicting results [41].…”
Section: Discussionsupporting
confidence: 81%
“…In our cohort, corticosteroid withdrawal showed a beneficial effect on glucose metabolism without compromising allograft outcome. This is in line with the recently published HARMONY trial [40]. However, studies investigating the benefit of corticosteroid withdrawal or avoidance for PTDM risk yielded conflicting results [41].…”
Section: Discussionsupporting
confidence: 81%
“…In the cyclosporin era, studies reported an increased rate of acute rejection (AR) and graft loss after steroid withdrawal compared with those after CSM . However, more recent immunosuppressive regimens have made SWA more feasible, and the safety of SWA therapy has been confirmed in patients receiving a calcineurin inhibitor or mycophenolate mofetil and induction with an IL‐2 receptor antagonist, alemtuzumab, or a polyclonal antibody [rabbit antithymocyte globulin (ATG)] . Recently, meta‐analyses, including trials conducted with new immunosuppressants, have corroborated the aforementioned finding that there was no difference in graft survival between patients on CSM and those on a steroid‐sparing protocol …”
Section: Introductionmentioning
confidence: 99%
“…CNI withdrawal, similarly, confers a higher risk of acute rejection (but not graft failure) . In patients with a low immunological risk profile, rapid steroid withdrawal has been nevertheless shown to be achievable after basiliximab or rabbit antithymocyte globulin induction therapy, with less post‐transplantation diabetes …”
Section: Maintenance Immunosuppression Therapymentioning
confidence: 99%